Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell ADMA Biologics Inc (ADMA) – ADMA Biologics Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

ADMA Biologics (ADMA) trades at $7.97, down 0.13% on the day, amid a bearish technical signal and significant negative news flow. The company maintains strong profitability with a 32.43% net income margin and 43.3% ROE, but faces headwinds from multiple securities fraud investigations and pricing pressure in its IG markets. Recent earnings have been mixed, with Q1 2026 missing expectations, and the stock is trading significantly below the analyst consensus price target of $19.00.
The outlook is clouded by legal and operational challenges, presenting high risk. While the valuation appears attractive with a P/E of 11.72, the potential for prolonged litigation and market pressures outweighs fundamental strength. The divergence between strong analyst ratings and negative technical/sentiment indicators suggests high uncertainty. Investment opportunity exists only for those with high risk tolerance betting on legal resolution and operational recovery.
Read full analysis

Key Stats

  • Market Cap
    $1.85B
  • Sector
    Health
  • 3M Drawdown
    -52.94%
  • Enterprise Value
    $1.91B
  • Dividend Yield
    -
  • Typical Hold Time
    10 days
$8
52W Low: $7.6
02 Jun 2026
52W High: $21.87
11 Jun 2025

ADMA Biologics Inc (ADMA) is currently valued at a market capitalization of $1.85B, with an enterprise value of $1.91B. Over the past 52 weeks, ADMA Biologics Inc has traded between a low of $7.6 and a high of $21.87, highlighting its annual price range. Over the past three months, ADMA Biologics Inc has recorded a drawdown of -52.94%, reflecting recent price volatility. On average, investors hold ADMA Biologics Inc for approximately 10 days, indicating typical investor behavior on the platform.

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.



People also bought


Global US Market Prices


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $1.85B
  • Sector
    Health
  • 3M Drawdown
    -52.94%
  • Enterprise Value
    $1.91B
  • Dividend Yield
    -
  • Typical Hold Time
    10 days
$8
52W Low: $7.6
02 Jun 2026
52W High: $21.87
11 Jun 2025

ADMA Biologics Inc (ADMA) is currently valued at a market capitalization of $1.85B, with an enterprise value of $1.91B. Over the past 52 weeks, ADMA Biologics Inc has traded between a low of $7.6 and a high of $21.87, highlighting its annual price range. Over the past three months, ADMA Biologics Inc has recorded a drawdown of -52.94%, reflecting recent price volatility. On average, investors hold ADMA Biologics Inc for approximately 10 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!